Literature DB >> 6350480

Thymopoietin-like substance in human skin.

A C Chu, J A Patterson, G Goldstein, C L Berger, S Takezaki, R L Edelson.   

Abstract

A heterologous antithymopoietin (anti-TP) antibody was used to determine whether a TP-like molecule is present in the epidermis, since such factors have been postulated to play a part in known T cell-epidermal cell interaction. Examination of cytocentrifuge smears of freshly separated human epidermal cells stained by indirect immunofluorescence revealed that 8-14% of these cells possessed cytoplasmic reactivity with the anti-TP antibody. Similarly, 2-5% of human epidermal cells, maintained in tissue culture for 2-8 weeks, showed cytoplasmic staining with the anti-TP antibody. Double-labeling immunofluorescence studies, with the anti-TP antibody and a monoclonal antibody specifically reactive with Langerhans cells (OKT6), demonstrated that cells possessing this TP-like substance were not Langerhans cells. In situ studies of 4-microns frozen sections of normal human skin indicated that the cell population which possesses the TP-like substance is the basal layer of keratincoytes in the epidermis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6350480     DOI: 10.1111/1523-1747.ep12517686

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Reactivity of T lymphotropic retrovirus antibody (12/1-2) in man: comparison of epidermis with other epithelial cells.

Authors:  E Ralfkiaer; K A Pulford; K C Gatter; G L Wantzin; D Y Mason
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

2.  Morphologic and immunophenotypic heterogeneity of corneal dendritic cells.

Authors:  L Catry; J Van den Oord; B Foets; L Missotten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

3.  Keratinocyte-derived T-cell growth factor: a T-cell growth factor functionally distinct from interleukin 2.

Authors:  T S Kupper; D L Coleman; J McGuire; D Goldminz; M C Horowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Isolation and complete amino acid sequence of human thymopoietin and splenin.

Authors:  T Audhya; D H Schlesinger; G Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

Review 5.  Thymopoietin to thymopentin: experimental studies.

Authors:  G Goldstein; T K Audhya
Journal:  Surv Immunol Res       Date:  1985

6.  Predominant cutaneous infiltration by OKT6- and OKT8-positive cells in a case of Sézary syndrome.

Authors:  K Meissner; T Löning; M Heckmayr; R Zschaber; M Jänner
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

Review 7.  Thymopentin and splenopentin as immunomodulators. Current status.

Authors:  V K Singh; S Biswas; K B Mathur; W Haq; S K Garg; S S Agarwal
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

8.  Homing of hemopoietic precursor cells to the embryonic thymus: characterization of an invasive mechanism induced by chemotactic peptides.

Authors:  P Savagner; B A Imhof; K M Yamada; J P Thiery
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

9.  Phenotypic characterization and ontogeny of mesodermal-derived and endocrine epithelial components of the human thymic microenvironment.

Authors:  B F Haynes; R M Scearce; D F Lobach; L L Hensley
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.